Clarion Medical Technologies, one of Canada’s largest private medical companies, and Hoya Vision Care Canada, a leading provider of precision prescription laboratory services and high-quality ophthalmic lenses, announce a strategic partnership that offers outstanding value and benefit to eyecare professionals.
This unique program provides the opportunity to acquire superior diagnostic technology and remarkable lens innovation in one combined offer. With the purchase or lease of any Clarion capital technology, credits are earned from Hoya which can be applied to the purchase or lease amount of the Clarion technology. The offer brings great value to ECPs by enabling new, essential technologies and products that support and enhance a progressive practice.
“We are pleased to be working with Clarion Medical Technologies on this program,” said David Pietrobon, president of Hoya Vision Care Canada. “They are a very strong partner in the Canadian vision industry. We both share a commitment and dedication to patient well-being and practice growth, as well as a commitment to cutting-edge technology.”
The strategic alliance has already enabled many ECPs to enjoy the benefits and value of increased purchasing power. The unique OCT programs based on the Optovue iVue and iWellness EXAM systems have been very well received in the marketplace as they offer improved eyecare at the comprehensive exam level through better diagnostics.
“Hoya Vision Care Canada was the perfect choice for this alliance, as their business philosophy and understanding of the optometrist’s needs are well aligned with Clarion’s. We both strive to provide the most innovative products that offer great patient care with a competitive advantage which is essential for successful practice growth in today’s optometric marketplace,” said Joseph Arango, executive vice president of Clarion Medical Technologies.
